Immunological consequences of compromised ocular immune privilege accelerate retinal degeneration in retinitis pigmentosa

Abstract Background Retinitis pigmentosa (RP) is a hereditary retinal disease which leads to visual impairment. The onset and progression of RP has physiological consequences that affects the ocular environment. Some of the key non-genetic factors which hasten the retinal degeneration in RP include...

Full description

Bibliographic Details
Main Authors: K. Varsha Mohan, Alaknanda Mishra, Abaranjitha Muniyasamy, Prakriti Sinha, Parul Sahu, Ashwani Kesarwani, Kshama Jain, Perumal Nagarajan, Vinod Scaria, Manisha Agarwal, Naseem S. Akhter, Chanda Gupta, Pramod Upadhyay
Format: Article
Language:English
Published: BMC 2022-10-01
Series:Orphanet Journal of Rare Diseases
Subjects:
Online Access:https://doi.org/10.1186/s13023-022-02528-x
_version_ 1811336300499828736
author K. Varsha Mohan
Alaknanda Mishra
Abaranjitha Muniyasamy
Prakriti Sinha
Parul Sahu
Ashwani Kesarwani
Kshama Jain
Perumal Nagarajan
Vinod Scaria
Manisha Agarwal
Naseem S. Akhter
Chanda Gupta
Pramod Upadhyay
author_facet K. Varsha Mohan
Alaknanda Mishra
Abaranjitha Muniyasamy
Prakriti Sinha
Parul Sahu
Ashwani Kesarwani
Kshama Jain
Perumal Nagarajan
Vinod Scaria
Manisha Agarwal
Naseem S. Akhter
Chanda Gupta
Pramod Upadhyay
author_sort K. Varsha Mohan
collection DOAJ
description Abstract Background Retinitis pigmentosa (RP) is a hereditary retinal disease which leads to visual impairment. The onset and progression of RP has physiological consequences that affects the ocular environment. Some of the key non-genetic factors which hasten the retinal degeneration in RP include oxidative stress, hypoxia and ocular inflammation. In this study, we investigated the status of the ocular immune privilege during retinal degeneration and the effect of ocular immune changes on the peripheral immune system in RP. We assessed the peripheral blood mononuclear cell stimulation by retinal antigens and their immune response status in RP patients. Subsequently, we examined alterations in ocular immune privilege machineries which may contribute to ocular inflammation and disease progression in rd1 mouse model. Results In RP patients, we observed a suppressed anti-inflammatory response to self-retinal antigens, thereby indicating a deviated response to self-antigens. The ocular milieu in rd1 mouse model indicated a significant decrease in immune suppressive ligands and cytokine TGF-B1, and higher pro-inflammatory ocular protein levels. Further, blood–retinal-barrier breakdown due to decrease in the expression of tight junction proteins was observed. The retinal breach potentiated pro-inflammatory peripheral immune activation against retinal antigens and caused infiltration of the peripheral immune cells into the ocular tissue. Conclusions Our studies with RP patients and rd1 mouse model suggest that immunological consequences in RP is a contributing factor in the progression of retinal degeneration. The ocular inflammation in the RP alters the ocular immune privilege mechanisms and peripheral immune response. These aberrations in turn create an auto-reactive immune environment and accelerate retinal degeneration.
first_indexed 2024-04-13T17:37:26Z
format Article
id doaj.art-f434b379cc6343818acff51001d5c769
institution Directory Open Access Journal
issn 1750-1172
language English
last_indexed 2024-04-13T17:37:26Z
publishDate 2022-10-01
publisher BMC
record_format Article
series Orphanet Journal of Rare Diseases
spelling doaj.art-f434b379cc6343818acff51001d5c7692022-12-22T02:37:19ZengBMCOrphanet Journal of Rare Diseases1750-11722022-10-0117111210.1186/s13023-022-02528-xImmunological consequences of compromised ocular immune privilege accelerate retinal degeneration in retinitis pigmentosaK. Varsha Mohan0Alaknanda Mishra1Abaranjitha Muniyasamy2Prakriti Sinha3Parul Sahu4Ashwani Kesarwani5Kshama Jain6Perumal Nagarajan7Vinod Scaria8Manisha Agarwal9Naseem S. Akhter10Chanda Gupta11Pramod Upadhyay12National Institute of ImmunologyNational Institute of ImmunologyNational Institute of ImmunologyNational Institute of ImmunologyNational Institute of ImmunologyNational Institute of ImmunologyNational Institute of ImmunologyNational Institute of ImmunologyCSIR Institute of Genomics and Integrative BiologyDr Shroff’s Charity Eye HospitalDr Shroff’s Charity Eye HospitalDr Shroff’s Charity Eye HospitalNational Institute of ImmunologyAbstract Background Retinitis pigmentosa (RP) is a hereditary retinal disease which leads to visual impairment. The onset and progression of RP has physiological consequences that affects the ocular environment. Some of the key non-genetic factors which hasten the retinal degeneration in RP include oxidative stress, hypoxia and ocular inflammation. In this study, we investigated the status of the ocular immune privilege during retinal degeneration and the effect of ocular immune changes on the peripheral immune system in RP. We assessed the peripheral blood mononuclear cell stimulation by retinal antigens and their immune response status in RP patients. Subsequently, we examined alterations in ocular immune privilege machineries which may contribute to ocular inflammation and disease progression in rd1 mouse model. Results In RP patients, we observed a suppressed anti-inflammatory response to self-retinal antigens, thereby indicating a deviated response to self-antigens. The ocular milieu in rd1 mouse model indicated a significant decrease in immune suppressive ligands and cytokine TGF-B1, and higher pro-inflammatory ocular protein levels. Further, blood–retinal-barrier breakdown due to decrease in the expression of tight junction proteins was observed. The retinal breach potentiated pro-inflammatory peripheral immune activation against retinal antigens and caused infiltration of the peripheral immune cells into the ocular tissue. Conclusions Our studies with RP patients and rd1 mouse model suggest that immunological consequences in RP is a contributing factor in the progression of retinal degeneration. The ocular inflammation in the RP alters the ocular immune privilege mechanisms and peripheral immune response. These aberrations in turn create an auto-reactive immune environment and accelerate retinal degeneration.https://doi.org/10.1186/s13023-022-02528-xRetinitis pigmentosaTight junction protein (TJP)Blood brain barrier (BRB)Immune infiltrationTransforming growth factor—beta 1 (TGF-B1)Retinal Degeneration 1 (rd1)
spellingShingle K. Varsha Mohan
Alaknanda Mishra
Abaranjitha Muniyasamy
Prakriti Sinha
Parul Sahu
Ashwani Kesarwani
Kshama Jain
Perumal Nagarajan
Vinod Scaria
Manisha Agarwal
Naseem S. Akhter
Chanda Gupta
Pramod Upadhyay
Immunological consequences of compromised ocular immune privilege accelerate retinal degeneration in retinitis pigmentosa
Orphanet Journal of Rare Diseases
Retinitis pigmentosa
Tight junction protein (TJP)
Blood brain barrier (BRB)
Immune infiltration
Transforming growth factor—beta 1 (TGF-B1)
Retinal Degeneration 1 (rd1)
title Immunological consequences of compromised ocular immune privilege accelerate retinal degeneration in retinitis pigmentosa
title_full Immunological consequences of compromised ocular immune privilege accelerate retinal degeneration in retinitis pigmentosa
title_fullStr Immunological consequences of compromised ocular immune privilege accelerate retinal degeneration in retinitis pigmentosa
title_full_unstemmed Immunological consequences of compromised ocular immune privilege accelerate retinal degeneration in retinitis pigmentosa
title_short Immunological consequences of compromised ocular immune privilege accelerate retinal degeneration in retinitis pigmentosa
title_sort immunological consequences of compromised ocular immune privilege accelerate retinal degeneration in retinitis pigmentosa
topic Retinitis pigmentosa
Tight junction protein (TJP)
Blood brain barrier (BRB)
Immune infiltration
Transforming growth factor—beta 1 (TGF-B1)
Retinal Degeneration 1 (rd1)
url https://doi.org/10.1186/s13023-022-02528-x
work_keys_str_mv AT kvarshamohan immunologicalconsequencesofcompromisedocularimmuneprivilegeaccelerateretinaldegenerationinretinitispigmentosa
AT alaknandamishra immunologicalconsequencesofcompromisedocularimmuneprivilegeaccelerateretinaldegenerationinretinitispigmentosa
AT abaranjithamuniyasamy immunologicalconsequencesofcompromisedocularimmuneprivilegeaccelerateretinaldegenerationinretinitispigmentosa
AT prakritisinha immunologicalconsequencesofcompromisedocularimmuneprivilegeaccelerateretinaldegenerationinretinitispigmentosa
AT parulsahu immunologicalconsequencesofcompromisedocularimmuneprivilegeaccelerateretinaldegenerationinretinitispigmentosa
AT ashwanikesarwani immunologicalconsequencesofcompromisedocularimmuneprivilegeaccelerateretinaldegenerationinretinitispigmentosa
AT kshamajain immunologicalconsequencesofcompromisedocularimmuneprivilegeaccelerateretinaldegenerationinretinitispigmentosa
AT perumalnagarajan immunologicalconsequencesofcompromisedocularimmuneprivilegeaccelerateretinaldegenerationinretinitispigmentosa
AT vinodscaria immunologicalconsequencesofcompromisedocularimmuneprivilegeaccelerateretinaldegenerationinretinitispigmentosa
AT manishaagarwal immunologicalconsequencesofcompromisedocularimmuneprivilegeaccelerateretinaldegenerationinretinitispigmentosa
AT naseemsakhter immunologicalconsequencesofcompromisedocularimmuneprivilegeaccelerateretinaldegenerationinretinitispigmentosa
AT chandagupta immunologicalconsequencesofcompromisedocularimmuneprivilegeaccelerateretinaldegenerationinretinitispigmentosa
AT pramodupadhyay immunologicalconsequencesofcompromisedocularimmuneprivilegeaccelerateretinaldegenerationinretinitispigmentosa